Adelpha Abrahamson Larkin
About Adelpha Abrahamson Larkin
Adelpha Abrahamson Larkin serves as the Senior Director and Head of Payer and Pricing Strategy at Day One Biopharmaceuticals. With extensive experience in market access strategies across neurology, oncology, and rare diseases, she has held various leadership roles in prominent pharmaceutical companies, including Genentech and BioMarin Pharmaceutical Inc.
Work at Day One Biopharmaceuticals
Adelpha Abrahamson Larkin serves as the Senior Director and Head of Payer and Pricing Strategy at Day One Biopharmaceuticals. In this role, she focuses on developing and implementing strategies that enhance product access and optimize pricing models. She has been with the company since 2022, contributing her extensive knowledge of market access and pricing strategies to support the company's objectives in the biopharmaceutical sector.
Previous Experience at Genentech
Adelpha Larkin held multiple roles at Genentech, where she gained significant experience in product management and market access. From 2014 to 2016, she worked as Group Manager for Cross Portfolio Pricing, Contracting, and Distribution. She later became the Group Product Manager for the Thrombolytics Franchise for eight months in 2016. Additionally, she served as Senior Strategy Manager for Pricing and Contracting Strategy in BioOncology from 2013 to 2014, and as Associate Director, Marketing; Access Lead from 2017 to 2019.
Experience at BioMarin Pharmaceutical Inc.
From 2019 to 2022, Adelpha Larkin worked at BioMarin Pharmaceutical Inc. as the Director of Market Access for Rare Disease. In this position, she was responsible for developing strategies that improved market access for rare disease products. Her tenure at BioMarin contributed to her deep understanding of the complexities involved in market access within the biopharmaceutical industry.
Consulting Background at BioMedical Insights
Adelpha Larkin worked as a Senior Consultant at BioMedical Insights from 2007 to 2012. During her five years in this role, she provided strategic consulting services that helped clients navigate market access challenges. This experience laid the foundation for her later roles in pricing and market strategy within the pharmaceutical sector.
Education and Expertise
Adelpha Larkin earned her Bachelor of Arts (B.A.) degree from Clark University. She possesses deep expertise in market access strategies, particularly in the fields of neurology, oncology, and rare diseases. Her educational background and professional experiences have equipped her with significant knowledge in pipeline planning and product development within the biotech and pharmaceutical industries.